Huge Deal. Some takeaways from me:
- Massive validation from a US $26B International Tech Company.
- Strategic investment. These guys will be sticky, no dumping on market after a quick 20% gain. Also the potential for them to take further stakes or even take over the whole company.
- Excellent cash runway. Approx $23m in cash with the potential for more grants. No dilution for a while.
- No 6% broker fees or options granted, deal done direct with Keysight at a favourable price.
- Any institutions or fund managers waiting for a raise will now be forced to buy on market.
- Founder led business with significant skin in the game. Well done Scott Kirkland and team.
- Forums
- ASX - By Stock
- Ann: Strategic A$15.28M Investment from Keysight Technologies
EMV
emvision medical devices ltd
Add to My Watchlist
3.74%
!
$1.81

Huge Deal. Some takeaways from me:- Massive validation from a US...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.81 |
Change
0.065(3.74%) |
Mkt cap ! $154.3M |
Open | High | Low | Value | Volume |
$1.74 | $1.81 | $1.74 | $18.26K | 10.38K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1988 | $1.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.80 | 8279 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1988 | 1.745 |
2 | 3798 | 1.740 |
1 | 156 | 1.735 |
2 | 1291 | 1.720 |
1 | 583 | 1.715 |
Price($) | Vol. | No. |
---|---|---|
1.795 | 8279 | 1 |
1.800 | 5975 | 2 |
1.810 | 1350 | 1 |
1.840 | 3000 | 1 |
1.845 | 1700 | 1 |
Last trade - 11.07am 01/07/2025 (20 minute delay) ? |
Featured News
EMV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online